Anti-Estrogen Receptor alpha antibody [SP1] (ab16660)

Publishing research using ab16660? Please let us know so that we can cite the reference in this datasheet.

ab16660 has been referenced in 19 publications.

  • He BX  et al. Association between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese females. Clin Exp Pharmacol Physiol 45:437-443 (2018). PubMed: 29272031
  • Guo C  et al. microRNA-10b expression and its correlation with molecular subtypes of early invasive ductal carcinoma. Exp Ther Med 15:2851-2859 (2018). PubMed: 29599829
  • Tian M & Schiemann WP TGF-ß Stimulation of EMT Programs Elicits Non-genomic ER-a Activity and Anti-estrogen Resistance in Breast Cancer Cells. J Cancer Metastasis Treat 3:150-160 (2017). PubMed: 28955730
  • Stock K  et al. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep 6:28951 (2016). IHC-P . PubMed: 27364600
  • Joseph JD  et al. The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. Elife 5:N/A (2016). IHC-P ; Mouse . PubMed: 27410477
  • Kangaspeska S  et al. Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer. BMC Cancer 16:378 (2016). PubMed: 27378269
  • Cheang TY  et al. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer. J Transl Med 14:54 (2016). PubMed: 26883017
  • Overcast WB  et al. Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study. Virchows Arch 469:203-12 (2016). PubMed: 27220765
  • Shah SH  et al. Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype. Cancer Biol Ther 16:1671-81 (2015). PubMed: 26186233
  • Xia X  et al. PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer. Oncol Lett 10:1501-1506 (2015). PubMed: 26622698
  • Holmström O  et al. Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner. PLoS One 10:e0144688 (2015). IHC . PubMed: 26659386
  • Coudyzer P  et al. Induction of post-menstrual regeneration by ovarian steroid withdrawal in the functionalis of xenografted human endometrium. Hum Reprod 30:1156-68 (2015). PubMed: 25750204
  • Lee JK  et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol 3:13 (2015). IF ; Human . PubMed: 25815289
  • Park SY  et al. Does background parenchymal enhancement on MRI affect the rate of positive resection margin in breast cancer patients? Br J Radiol 88:20140638 (2015). PubMed: 25429418
  • Varghese F  et al. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One 9:e96801 (2014). IHC-P ; Human . PubMed: 24802416
  • Pape-Zambito D  et al. Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients. PLoS One 9:e100488 (2014). IHC-P ; Human . PubMed: 24978026
  • Babayan A  et al. Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients. PLoS One 8:e75038 (2013). PubMed: 24058649
  • Huang Z  et al. Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol 13:91-5 (2005). PubMed: 15722800
  • Cano G  et al. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol 29:207-11 (2003). PubMed: 14506673


Sign up